Q2 FY26Published 13 Nov 2025Call held 13 Nov 2025
OSELDEVICE Q2 FY26 Earnings Call Transcript & Analysis
Hearing aids contributed ~35% of revenue with 30-35% gross margins.
Read full transcript & analysis
Earnings calls
OSEL Devices concall ledger
Every earnings call for OSELDEVICE — management tone, guidance, KPIs and promise tracking, quarter by quarter.
OSELDEVICE · 2 transcripts · Healthcare · latest Q2 FY26Q4 FY25Published 27 May 2025Call held 27 May 2025
OSELDEVICE Q4 FY25 Earnings Call Transcript & Analysis
FY25 EBITDA Margin18%
FY25 EBITDA Margin 18.0%. H2 FY25 revenue estimated at ₹99 crores, with Q4 FY25 revenue around ₹45-50 crores.
Read full transcript & analysis